+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Interplay between estrogen and retinoid signaling in breast cancer--current and future perspectives

Interplay between estrogen and retinoid signaling in breast cancer--current and future perspectives

Cancer Letters 353(1): 17-24

All-trans-retinoic acid (RA) is a promising agent for breast cancer treatment, but it induces several adverse effects and the few clinical trials performed up to now in breast cancer patients have provided disappointing results. The combination of RA and antiestrogenic compounds, such as tamoxifen, synergistically decreases the proliferation of breast cancer cells and an interplay between retinoid and estrogen signaling has begun to be unraveled, turning these combinations into an appealing strategy for breast cancer treatment. This review focus on the current knowledge regarding the interplay between retinoid and estrogen signaling in breast cancer and the combinations of RA with antiestrogens, aiming their future utilization in cancer therapy.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 053924659

Download citation: RISBibTeXText

PMID: 25042865

DOI: 10.1016/j.canlet.2014.07.009

Related references

Interplay between inflammatory and estrogen signaling in breast cancer. Cytokine 76(2): 588-590, 2015

The Japanese Breast Cancer Society Breast Cancer Registry in the National Clinical Database: current status and future perspectives. Nihon Geka Gakkai Zasshi 115(1): 17-21, 2014

Treatment of estrogen-receptor positive breast cancer and estrogen-receptor negative breast cancer with retinoid with CH2 OH at the side chain terminal position. Official Gazette of the United States Patent & Trademark Office Patents 1240(3), 2000

Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocrine Reviews 15(1): 61-79, 1994

Breast cancer imaging--current technologies and future perspectives. Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl. 6): 231-234, 2007

Targeting cell death signaling in colorectal cancer: current strategies and future perspectives. World Journal of Gastroenterology 20(8): 1923-1934, 2014

Current Status and Future Perspectives on Tamoxifen in Breast Cancer Treatment. Breast Cancer 5(4): 347-348, 1998

CDK4/6 blockade in breast cancer: current experience and future perspectives. Expert Opinion on Investigational Drugs 26(12): 1357-1372, 2017

Infertility and pregnancy after breast cancer: current knowledge and future perspectives. Cancer Treatment Reviews 32(6): 417-422, 2006

Antiangiogenic therapy for breast cancer current status and future perspectives. The Chinese-German Journal of Clinical Oncology 10(7): 373-379, 2011

New drugs in breast cancer therapy: Current position and future perspectives. Gynaekologisch-Geburtshilfliche Rundschau 37(2): 54-61, 1997

Dose intensification and breast cancer: current results and future perspectives. Annals of Oncology 7(Suppl. 2): 31-40, 1996

Breast Cancer Immunology and Immunotherapy: Current Status and Future Perspectives. International Review of Cell and Molecular Biology 331: 1-53, 2017

Bevacizumab and breast cancer: current therapeutic progress and future perspectives. Expert Review of Anticancer Therapy 9(12): 1715-1725, 2009

Locally advanced breast cancer in Brazil: current status and future perspectives. Ecancermedicalscience 13: 895, 2019